ClinicalTrials.gov
public full text
Public Domain
Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
Current therapies for Stage III or Stage IV Prostate Cancer provide very limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of Stage III or Stage IV Prostate Cancer. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on patients with Stage III or Stage IV Prostate Cancer.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate Cancer#855855
- Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the Bladder#856227
- Brachytherapy in Treating Patients With Recurrent Prostate Cancer#1113920
- Duration of Medication Therapy and Outcomes After Holmium Laser Prostate Surgery for Patients With Benign Prostatic Hyperplasia (BPH)#846637
- First-in-man Dose Escalation Study of BAY2010112 in Patients With Prostate Cancer#862073
Record · ID 847195
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive